Literature DB >> 26961956

The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.

Fucheng Luo1, Jessie Zhang1, Kathryn Burke2, Robert H Miller3, Yan Yang4.   

Abstract

The regulation of oligodendrocyte development and myelin formation in the CNS is poorly defined. Multiple signals influence the rate and extent of CNS myelination, including the noncanonical cyclin-dependent kinase 5 (Cdk5) whose functions are regulated by its activators p35 and p39. Here we show that selective loss of either p35 or p39 perturbed specific aspects of oligodendrocyte development, whereas loss of both p35 and p39 completely inhibited the development of mature oligodendrocytes and myelination. In the absence of p35, oligodendrocyte differentiation was delayed, process outgrowth was truncated in vitro, and the patterning and extent of myelination were perturbed in the CNS of p35(-/-) mice. In the absence of p39, oligodendrocyte maturation was transiently affected both in vitro and in vivo. However, loss of both p35 and p39 in oligodendrocyte lineage cells completely inhibited oligodendrocyte progenitor cell differentiation and myelination both in vitro and after transplantation into shiverer slice cultures. Loss of p35 and p39 had a more profound effect on oligodendrocyte development than simply the loss of Cdk5 and could not be rescued by Cdk5 overexpression. These data suggest p35 and p39 have specific and overlapping roles in oligodendrocyte development, some of which may be independent of Cdk5 activation.
Copyright © 2016 the authors 0270-6474/16/363024-14$15.00/0.

Entities:  

Keywords:  Cdk5; maturation; myelination; oligodendrocyte; p35; p39

Mesh:

Substances:

Year:  2016        PMID: 26961956      PMCID: PMC4783501          DOI: 10.1523/JNEUROSCI.2250-15.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

Review 1.  Regulation of oligodendrocyte development in the vertebrate CNS.

Authors:  Robert H Miller
Journal:  Prog Neurobiol       Date:  2002-08       Impact factor: 11.685

2.  Cell death and control of cell survival in the oligodendrocyte lineage.

Authors:  B A Barres; I K Hart; H S Coles; J F Burne; J T Voyvodic; W D Richardson; M C Raff
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

3.  Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes.

Authors:  X M Tang; P Strocchi; F Cambi
Journal:  J Cell Biochem       Date:  1998-01-01       Impact factor: 4.429

4.  Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality.

Authors:  T Chae; Y T Kwon; R Bronson; P Dikkes; E Li; L H Tsai
Journal:  Neuron       Date:  1997-01       Impact factor: 17.173

5.  Redundancy of class III POU proteins in the oligodendrocyte lineage.

Authors:  J Schreiber; J Enderich; E Sock; C Schmidt; C Richter-Landsberg; M Wegner
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

6.  Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.

Authors:  Jong-Hee Lee; Kyong-Tai Kim
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

7.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Different neuroligands and signal transduction pathways stimulate CREB phosphorylation at specific developmental stages along oligodendrocyte differentiation.

Authors:  C Sato-Bigbee; S Pal; A K Chu
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

9.  A novel disruption of cortical development in p35(-/-) mice distinct from reeler.

Authors:  Y T Kwon; L H Tsai
Journal:  J Comp Neurol       Date:  1998-06-15       Impact factor: 3.215

10.  Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation.

Authors:  Fei Chen; Qing Wang; Xuening Wang; George P Studzinski
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

View more
  13 in total

1.  DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia.

Authors:  Kai-Hei Tse; Aifang Cheng; Fulin Ma; Karl Herrup
Journal:  Alzheimers Dement       Date:  2018-01-09       Impact factor: 21.566

2.  Apolipoprotein E ε4 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease.

Authors:  Gerald Wai-Yeung Cheng; Kingston King-Shi Mok; Sunny Hoi-Sang Yeung; Julia Kofler; Karl Herrup; Kai-Hei Tse
Journal:  J Neuropathol Exp Neurol       Date:  2022-08-16       Impact factor: 3.148

3.  Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient Mice.

Authors:  Miyuki Takahashi; Toshiyuki Takasugi; Arisa Kawakami; Ran Wei; Kanae Ando; Toshio Ohshima; Shin-Ichi Hisanaga
Journal:  Neurochem Res       Date:  2022-06-08       Impact factor: 4.414

4.  Oligodendrocyte-specific loss of Cdk5 disrupts the architecture of nodes of Ranvier as well as learning and memory.

Authors:  Fucheng Luo; Jessie Zhang; Kathryn Burke; Rita R Romito-DiGiacomo; Robert H Miller; Yan Yang
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

5.  NaviSE: superenhancer navigator integrating epigenomics signal algebra.

Authors:  Alex M Ascensión; Mikel Arrospide-Elgarresta; Ander Izeta; Marcos J Araúzo-Bravo
Journal:  BMC Bioinformatics       Date:  2017-06-06       Impact factor: 3.169

6.  Thioredoxin-1 Protects Spinal Cord from Demyelination Induced by Methamphetamine through Suppressing Endoplasmic Reticulum Stress and Inflammation.

Authors:  Lihua Yang; Yinli Guo; Mengbin Huang; Xiaoli Wu; Xiang Li; Guobing Chen; Ye Li; Jie Bai
Journal:  Front Neurol       Date:  2018-02-06       Impact factor: 4.003

7.  An Improved in vitro Model of Cortical Tissue.

Authors:  Aaron Gilmour; Laura Poole-Warren; Rylie A Green
Journal:  Front Neurosci       Date:  2019-12-17       Impact factor: 4.677

8.  Peripheral and orofacial pain sensation is unaffected by the loss of p39.

Authors:  Michaela Prochazkova; Bradford Hall; Minghan Hu; Tracy Okine; Jennifer Reukauf; B K Binukumar; Niranjana D Amin; Eva Roque; Harish C Pant; Ashok Kulkarni
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

9.  Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis.

Authors:  Fucheng Luo; Amanda Phuong Tran; Li Xin; Chandrika Sanapala; Bradley T Lang; Jerry Silver; Yan Yang
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

Review 10.  Pharmacotherapy of Alzheimer's Disease: Seeking Clarity in a Time of Uncertainty.

Authors:  Nurul Husna Ibrahim; Mohamad Fairuz Yahaya; Wael Mohamed; Seong Lin Teoh; Chua Kien Hui; Jaya Kumar
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.